PharmaShots | Incisive News in 3 Shots

Subscribe Now

Mutational

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as Monotherapy for Patients with Unresectable or Metastatic Tumor Mutational Burden-High Solid Tumors

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as Monotherapy for Patients with Unresectable or Metastatic Tumor...

June 18, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us